Article
Exercising the Sanger Sequencing Strategy for Variants Screening and Full-Length Genome of SARS-CoV-2 Virus during Alpha, Delta, and Omicron Outbreaks in Hiroshima.
Viruses - 30 Mar 2022
Ko Ko, Takahashi Kazuaki, Nagashima Shintaro, E Bunthen, Ouoba Serge, Takafuta Toshiro, Fujii Yoshiki, Mimori Michi, Okada Fumie, Kishita Eisaku, Ariyoshi Kunie, Hussain Md Razeen Ashraf, Sugiyama Aya, Akita Tomoyuki, Kuwabara Masao, Tanaka Junko
Abstract excerpt
This study aimed to exercise the Sanger sequencing strategy for screening of variants among confirmed COVID-19 cases and validate our strategy against NGS strains in Hiroshima retrieved from GISAID. A total of 660 samples from confirmed COVID-19 cases underwent screening for variants by Sanger-based partial sequencing to the targeted spike gene (nt22,735~nt23,532) using an in-house-developed primer set. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
